Hantech Bio-Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	264.32	249.4	382.42	167.09	75.04	86.41
Trading Asset Securities	89.99	89.99	-	-	-	-
Cash & Short-Term Investments	354.3	339.38	382.42	167.09	75.04	86.41
Cash Growth	-2.65%	-11.25%	128.87%	122.67%	-13.16%	5.66%
Accounts Receivable	127.84	133.93	80.56	88.43	50.06	24.94
Other Receivables	2.67	1.59	0.21	0.21	0.01	0.01
Receivables	130.52	135.51	80.76	88.64	50.07	24.95
Inventory	116.56	112.06	70.34	80.47	29.32	22.04
Prepaid Expenses	3.44	1.35	1.11	3.72	4.24	1.78
Other Current Assets	3.23	3.23	-	-	-	-
Total Current Assets	608.05	591.53	534.63	339.91	158.68	135.17
Property, Plant & Equipment	567.28	558.71	566.87	551.32	285.23	227.04
Other Intangible Assets	3.33	3.95	5.96	3.25	1.47	1.2
Long-Term Deferred Tax Assets	2.45	2.61	1.79	1.81	2.27	1.06
Other Long-Term Assets	12.56	9.53	9.75	34.65	25.95	11.17
Total Assets	1,194	1,166	1,119	930.94	473.59	375.65
Accounts Payable	101.59	115.69	46.33	99.17	33.7	13.67
Accrued Expenses	51.46	63.66	43.56	49.75	25.29	25.4
Short-Term Debt	-	-	-	-	1	4
Current Portion of Long-Term Debt	15.38	24.37	51.22	23.18	5.94	5.06
Current Portion of Leases	8.07	5.75	6.26	6.63	6.57	6.78
Current Income Taxes Payable	26.98	16.48	21.73	30.01	8.91	0.97
Current Unearned Revenue	17.26	16.88	13.25	10.38	13.51	10.24
Other Current Liabilities	3.95	3.64	9.86	5.22	1.82	1.21
Total Current Liabilities	224.69	246.47	192.21	224.34	96.74	67.35
Long-Term Debt	65.76	69.3	92.25	285.1	84.48	110.37
Long-Term Leases	23.76	13.86	9.1	15.35	20.84	18.53
Long-Term Unearned Revenue	4.44	4.46	4.57	4.77	2.95	1.49
Long-Term Deferred Tax Liabilities	0.03	0.01	0.05	-	0.01	-
Total Liabilities	318.68	334.1	298.18	529.56	205.02	197.74
Common Stock	305.72	305.72	276.01	193.67	166.34	113.46
Additional Paid-In Capital	313.77	313.75	296.21	36.88	36.85	12.31
Retained Earnings	280.78	238.06	245.56	167.55	63.7	48.85
Treasury Stock	-28.36	-28.36	-	-	-	-
Total Common Equity	871.91	829.16	817.78	398.09	266.89	174.62
Minority Interest	3.07	3.07	3.04	3.29	1.68	3.3
Shareholders' Equity	874.98	832.23	820.82	401.38	268.57	177.91
Total Liabilities & Equity	1,194	1,166	1,119	930.94	473.59	375.65
Total Debt	112.97	113.28	158.83	330.27	118.83	144.75
Net Cash (Debt)	241.33	226.1	223.6	-163.18	-43.79	-58.33
Net Cash Growth	10.09%	1.12%	-	-	-	-
Net Cash Per Share	6.58	6.15	6.38	-4.80	-1.40	-2.01
Filing Date Shares Outstanding	36.33	36.33	36.46	33.26	32.85	27.89
Total Common Shares Outstanding	36.33	36.33	36.46	33.26	32.85	27.89
Working Capital	383.36	345.06	342.42	115.57	61.94	67.83
Book Value Per Share	24.00	22.83	22.43	11.97	8.12	6.26
Tangible Book Value	868.58	825.22	811.82	394.84	265.42	173.42
Tangible Book Value Per Share	23.91	22.72	22.27	11.87	8.08	6.22
Land	214.44	214.44	214.44	214.44	87.04	87.04
Buildings	265.52	264.95	260.13	241.98	-	6.2
Machinery	162.68	159.98	149.35	113.95	87.08	83.76
Construction In Progress	-	-	-	9.78	125.77	61.92
Leasehold Improvements	5.5	5.5	7.43	7.4	7.36	1.02